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We have learned much about the human microbiome,
especially with advances in sequencing. However, as
with the human genome, translating this knowledge into
therapies remains challenging. One key advantage of
focusing on the microbiome is that, outside of Star
Trek, our genomes change little during our lifetime, yet
each of our microbiomes has changed profoundly. Our
microbiomes develop from an undifferentiated state that
is dependent on delivery mode (i.e. vaginal delivery ver-
sus C-section) to the highly distinct communities that
populate every crevice of our bodies.
Here I discuss the variation in the human microbiome
within and between people, with a focus on the impor-
tance of spatially and temporally resolved studies, and
the use of animal models, to gain insight into the role of
microbes in obesity. Interestingly, many features of the
microbiota of humans can be transferred into mice. The
prospects for building a translational medicine pipeline,
in which a single stool sample can be used to predict
which interventions will work for which person, are
compelling.
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